-
Rat Insulin ELISA Jumbo Pack (10 Plates)Catalog #: 80-INSRT-E10
Sensitivity: 0.124 ng/mL
Range: 0.15 - 5.5 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 10 x 96 Wells
Detection: Colorimetric -
Ultrasensitive Insulin ELISA
Catalog #: 80-INSHUU-E01.1
Sensitivity: 0.135 µIU/mL
Range: 0.15 - 20 µIU/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Bovine Insulin ELISA
Catalog #: 80-INSBO-E01
Sensitivity: 0.10 ng/mL
Range: 0.25 - 6.0 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Insulin ELISA Jumbo Pack (10 Plates)
Catalog #: 80-INSHU-E10.1
Sensitivity: 0.399 µIU/mL
Range: 3 - 200 µIU/mL
Sample Types: Plasma, Serum
Sample Size(s): 10 x 96 Wells
Detection: Colorimetric -
Ultrasensitive Insulin ELISA Jumbo Pack (10 Plates)
Catalog #: 80-INSHUU-E10
Sensitivity: 0.135 µIU/mL
Range: 0.15 - 20 µIU/mL
Sample Types: Plasma, Serum
Sample Size(s): 10 x 96 Wells
Detection: Colorimetric -
Insulin ELISA
Catalog #: 80-INSHU-E01.1
Sensitivity: 0.399 µIU/mL
Range: 3 - 200 µIU/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Mouse Insulin ELISA Jumbo Pack (10 Plates)
Catalog #: 80-INSMS-E10
Sensitivity: 0.06 ng/mL
Range: 0.188 - 6.9 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 10 x 96 Wells
Detection: Colorimetric -
Mouse Ultrasensitive Insulin ELISA Jumbo Pack (10 Plates)
Catalog #: 80-INSMSU-E10
Sensitivity: 0.115 ng/mL (5 µL), 0.019 ng/mL (25 µL)
Range: 0.025 - 6.9 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 10 x 96 Wells
Detection: Colorimetric -
Mouse Ultrasensitive Insulin ELISA
Catalog #: 80-INSMSU-E01
Sensitivity: 0.115 ng/mL (5 µL), 0.019 ng/mL (25 µL)
Range: 0.025 - 6.9 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Rat Ultrasensitive Insulin ELISA
Catalog #: 80-INSRTU-E01
Sensitivity: 0.107 ng/mL (5 µL), 0.002 ng/mL (25 µL)
Range: 0.15 - 5.5 or 0.02 - 1.0 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Rat Insulin ELISA
Catalog #: 80-INSRT-E01
Sensitivity: 0.124 ng/mL
Range: 0.15 - 5.5 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Mouse Insulin ELISA
Catalog #: 80-INSMS-E01
Sensitivity: 0.06 ng/mL
Range: 0.188 - 6.9 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric
Tips & Tricks
The Enzyme-Linked Immunosorbent Assay (ELISA) is a proven sensitive method for detecting and quantifying specific biomarkers in a wide range of clinical and research samples. The accuracy and precision of ELISAs can be affected by many factors, including pipetting, washing, and sample-handling techn...
Responsibility
ALPCO’s Diabetes Research Travel GrantALPCO strives to provide scientists and healthcare professionals with robust tools for their research and clinical diagnostic endeavors. We understand that championing extraordinary discoveries requires extraordinary efforts, and support. We are proud to continu...
Multiplex Biomarker Instrumentation
Discover Automated Multiplex Testing to Simplify Batch AnalysisALPCO has partnered with DYNEX® Technologies to leverage the DYNEX Multiplier® powered by SmartPlex® technology to fully automate multiplex analysis of novel protein biomarkers.DYNEX Multiplier® Automated Chemiluminescence AnalyzerThe DY...
ELISA Instrumentation
Automate
ELISA Testing to Improve Performance and Productivity Shifting from manual ELISA processing to automation helps reduce variability and improve analytical performance. ALPCO offers automation to optimize workflow, capacity, and productivity.DYNEX DS2® 2-Plate ELISA Processing SystemCompact....
A Comparison of Colorimetric and Chemiluminescence ELISAs
Are you curious about chemiluminescence ELISAs, but not exactly sure what they are, or how to use them? Our video A Comparison of Colorimetric and Chemiluminescence ELISAs discusses how similar these two types of assays are, and how they can enhance your lab testing.
Watch our video to:
Lear...
12 ELISA Tips and Tricks: An Expert’s Guide to Improve Your Technique
The Enzyme-Linked Immunosorbent Assay (ELISA) is a proven sensitive method for detecting and quantifying specific biomarkers in a wide range of clinical and research samples. The accuracy and precision of ELISAs can be affected by many factors, including pipetting, washing, and sample-handling techn...
ALPCO to Feature New STELLUX® Chemi Active GLP-1 (7-36) amide ELISA and Young Investigators Travel Grant Program at ADA’s 78th Scientific Sessions
June 19, 2018
ALPCO, a leading producer of research and clinical immunoassays, announced it will showcase its new STELLUX® Chemi Active GLP-1 (7-36) amide ELISA at the American Diabetes Association’s 78th Scientific Sessions June 23-25, 2018 in Orlando, FL. This new addition to the STELLUX® Chem...
Proinsulin, Insulin and Beta Cell Dysfunction
UBC Professor Bruce Verchere, PhD discusses the significance of proinsulin and insulin as biomarkers to probe beta cell dysfunction.
https://www.youtube.com/watch?v=HM5FN3D5VxI
Role of IGF-1 in the Growth Hormone/IGF Axis
The Growth Hormone/IGF axis consists of IGF-1, IGF-2 and several high and low affinity IGF Binding Proteins (IGFBP). The whole system is tightly regulated by a feedback loop involving Growth Hormone (GH) secreted by the pituitary, and GH production and secretion controlled by Growth Hormone Releasin...
Bone Metabolism: The Cycle of Bone Growth and Resorption
Bone metabolism is a continual cycle of bone growth and resorption that is carefully orchestrated by the dynamic relationship between osteoclasts, osteoblasts and an array of hormonal and regulatory influences. The relative levels of these signaling molecules dictate whether healthy, balanced bo...
Understanding the Role of Energy Homeostasis in Diabetes
Introduction
The prevalence of diabetes and obesity has been on the rise for several decades and research has demonstrated that other parts of the body, including the cardiovascular system and kidneys, can be affected by diabetes. The key to understanding the relationship between diabetes and the...
Heart Disease Biomarkers in Diabetes Research
Introduction
Cardiovascular disease (CVD) encompasses a constellation of diseases related to the heart and circulatory system. Despite efforts to understand and combat CVD complications from diabetes, 65% of diabetics will pass away from cardiovascular issues1. Part 2 of The Common Denominator eBoo...
Early Detection of Diabetic Kidney Disease with Biomarkers
Introduction
Over one third of diabetics will develop diabetic kidney disease (DKD) in their lifetime1. Despite the large amount of diabetics suffering from DKD, current methods for measuring and tracking kidney function may not be specific enough for diabetic systems2,3.
Part III of The Common ...
The Changing Roles of Bone Remodeling Biomarkers
Introduction
Bones are traditionally known for their support, protection and movement properties, as well as their role in the processes of mineral balance and blood cell production. Research supports that bones do more than they were originally recognized for. Previous research investigating osteo...
Customer Spotlight: Measuring Functionality of Islet Microtissues
Date: July 26, 2016
Beta cell generation has gained much traction in recent years among diabetes researchers. Investigators are not only converting adipose tissue and skin cells into beta cells, they are also starting to grow beta cells in a petri dish in vitro. Swiss company InSphero has begun m...
Choosing the Relevant GLP-1 Species to Study
A better understanding of incretins has led to tremendous therapeutic advances in the field of type 2 diabetes1. These hormones are released from the gut in response to food ingestion and lead to the stimulation of pancreatic β-cells which then release insulin in a glucose-concentration de...
Emerging Biomarker Research in NAFLD and NASH
Nonalcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver disease in the western hemisphere affecting 1 in 3 adults and 1 in 10 children1. Today, liver biopsies are the only gold standard for precise diagnosis of NAFLD2. Because of this, there are tremendous efforts on the ...
ALPCO and InSphero Collaborate to Advance Metabolic Disease Research at ADA 2017
Date: June 6, 2017
ALPCO announced it will collaborate with InSphero, a supplier of 3D cell culture solutions, at the ADA’s 77th Scientific Sessions June 10-12 in San Diego. Together, ALPCO and InSphero aim to enhance the study of islet function, regeneration, and preservation by providing resear...
Adipokines and Adipose Tissue-Liver Crosstalk in Energy Metabolism
Research over the past several decades examining adipokines and adipose tissue-liver crosstalk in energy metabolism has revealed that adipose tissue is a very important metabolically active endocrine organ1. White, brown, and beige adipose tissue generate and secrete adipokines, such as adiponectin ...
Obesity Induced Adipose Tissue Dysfunction and NAFLD
Obesity is a known risk factor for developing metabolic diseases such as non-alcoholic fatty liver disease (NAFLD)1. An increasing amount of evidence shows that obesity induced adipose tissue dysfunction and NAFLD development are closely related2. Obesity induced changes to adipokine secretion can h...
Researching the Role of Gut Permeability in NAFLD
[playlist images="false" artists="false" tracklist="false" ids="4600"]
A growing amount of research demonstrates that communication between the gut microbiota and liver is vital for the regulation of energy metabolism1,2. As a result, scientists are further...
Dorothy Hodgkin’s Discovery of Insulin's 3D Structure
Nobel Prize winning British chemist Dr. Dorothy Hodgkin significantly contributed to unraveling the secrets of diabetes mellitus. She is considered a founder of X-ray crystallography, a technique used to discern the structures of organic biomolecules. Dorothy Hodgkin’s discovery of insulin's 3D...
Organ Crosstalk in Obesity and NAFLD
The liver is vital to various metabolic functions including lipid and glucose metabolism. In order to maintain homeostasis, efficient gut-liver and adipose tissue-liver communications are needed1,2. Research indicates that obesity induced dysfunctions within these crosstalks can lead to imbalances i...
ALPCO and InSphero Partner to Offer a Complete Solution to Assess Beta-cell Function in Islet Microtissue Culture Models
July 23, 2018
ALPCO recently announced its partnership with InSphero, AG to provide customers with a complete solution to assess beta-cell function in islet microtissue culture models. InSphero’s 3D InSight™ Diabetes Discovery Platform offers users a comprehensive beta-cell function applic...